podcast.de
Anmeldung
Anmeldung Registrierung
Auto Hell Dunkel
Erweiterte Suche
  1. Startseite
  2. Podcasts
  3. Medizin - Open Access LMU - Teil 15/22 Podcast
  4. Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials
Background: Recent reviews on placebo effects in clinical trials
suggest that objective changes following placebo treatments may not
exist or, at least, have been considerably overestimated. However,
the possibility that yet unidentified subsets of parameters are
responsive to placebo treatments has not been taken into account.
Therefore, the aim of the present study is to examine the effects
of placebo treatments on objectively measured outcome parameters by
specifically focusing on peripheral disease processes. Methods: An
initial dataset was collected from a MEDLINE search for
placebo-controlled, randomized clinical trials. Trials with stable
disease conditions were identified, and the effects of placebo
treatments on peripheral outcome parameters were estimated by the
changes from baseline in the placebo groups. An explorative data
analysis was conducted in order to identify parameter classes with
differential responsiveness to placebo treatments. A subgroup
meta-analysis of a second dataset was performed to test whether the
preliminary classification would also apply to placebo effects
derived from the comparison of placebo groups with untreated
control groups. Results: The explorative analysis of outcome
parameters and strength of placebo effects yielded a classification
into responsive "physical" versus non-responsive "biochemical"
parameters. In total, 50% of trials measuring physical parameters
showed significant placebo effects, compared with 6% of trials
measuring biochemical parameters. A subgroup meta-analysis
substantiated the differential response ( physical parameters: n =
14, Hedges' pooled effect size g = 0.34, 95% CI 0.22 to 0.46;
biochemical parameters: n = 15, g = 0.03, 95% CI - 0.04 to 0.10).
The subanalysis of the second dataset supported the classification
and revealed a significant improvement for physical parameters ( n
= 20, g = 0.22, 95% CI 0.07 to 0.36) and a deterioration for
biochemical parameters ( n = 6, g = - 0.17, 95% CI - 0.31 to -
0.02). Conclusion: The results suggest that placebo interventions
can improve physical disease processes of peripheral organs more
easily and effectively than biochemical processes. This
differential response offers a good starting point for theoretical
considerations on possible mediating mechanisms, and for future
investigations in this field.

Weitere Episoden

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

Report of the Working Group `Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)'

vor 17 Jahren
Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

Intranasal insulin to improve developmental delay in children with 22q13 deletion syndrome: an exploratory clinical trial

vor 17 Jahren
Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

Guidelines for initiation of anti-tumour necrosis factor therapy in rheumatoid arthritis: similarities and differences across Europe.

vor 17 Jahren
JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand.

vor 17 Jahren
Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

Influence of peptidylarginine deiminase type 4 genotype and shared epitope on clinical characteristics and autoantibody profile of rheumatoid arthritis.

vor 17 Jahren
Alle Episoden anzeigen
In Podcasts werben
Schalte jetzt Werbung in Podcasts.
Episode melden

„Evidence for placebo effects on physical but not on biochemical outcome parameters: a review of clinical trials“

Worum geht es? Danach fragen wir noch nach dem Grund.

Abonnenten

Teilen

Mein Archiv

Deine Privatkopie der Folgen, die du nicht verlieren willst.

Podcast-Folgen verschwinden. Feeds werden auf die letzten Episoden gekürzt, Hoster räumen alte Dateien ab, Formate wechseln den Anbieter und lassen ihr Archiv zurück. Mit „Mein Archiv“ sichert podcast.de die Folgen deiner Podcasts für dich — angefangen bei den ältesten, denn die sind zuerst weg.

  • Deine gesicherten Folgen bleiben hörbar, auch wenn das Original offline geht.
  • Auch Folgen, die im heutigen Feed gar nicht mehr stehen — podcast.de kennt sie noch.
  • Herunterladen bleibt möglich, solange die Folge beim Podcaster liegt. Der zählt seine Abrufe wie bisher.
Startet bald

Sei beim Start von Mein Archiv dabei

Mein Archiv ist fast fertig. Trag dich ein, dann bekommst du eine E-Mail, sobald es losgeht – und bist von Anfang an dabei. Wir schreiben dir nur zum Start, keine Werbung, keine Weitergabe deiner Daten.

Du bekommst zuerst eine Bestätigungsmail. Abmelden geht jederzeit. Datenschutz